Literature DB >> 340297

Determination of thymidine in serum used for cell culture media.

J C Schaer, U Maurer, R Schindler.   

Abstract

Thymidine concentrations in serum used for cell culture media were determined with an assay based on isotope dilution. In this assay, incorporation of (3H)-thymidine into DNA of cultured cells was measured in the presence of 5 and 20% serum as a function of the concentration of unlabeled thymidine added to the medium. In three batches of horse serum, thymidine concentrations were 0--0.17 micron, while in fetal calf serum values of 0.75--2.1 micron were obtained. Dialysis of serum resulted in a reduction of thymidine levels by factors of at least 10.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 340297     DOI: 10.1159/000162879

Source DB:  PubMed          Journal:  Exp Cell Biol        ISSN: 0304-3568


  5 in total

1.  A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine.

Authors:  Ning Guo; Jingping Xie; H Charles Manning; Natasha G Deane; M Sib Ansari; Robert J Coffey; John Gore; Ronald R Price; Ronald M Baldwin; J Oliver McIntyre
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

2.  Adaptation of thymidine utilization to changing rates of DNA synthesis in the cell cycle.

Authors:  G G Miller; J C Schaer; J R Gautschi; R Schindler
Journal:  Mol Cell Biochem       Date:  1979-09-28       Impact factor: 3.396

Review 3.  Physiological concentrations of purines and pyrimidines.

Authors:  T W Traut
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

4.  Relative resistance to methotrexate by proliferating normal rabbit epidermal cells in vitro.

Authors:  R A Harper; B A Flaxman
Journal:  In Vitro       Date:  1981-05

5.  Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.

Authors:  Y Sugimoto; Y Ohe; K Nishio; T Ohmori; T Morikage; Y Fujiwara; N Saijo
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.